Cadence Bank Invests $3.62 Million in Zoetis Inc. $ZTS

Key Points

• Cadence Bank opened a new position in Zoetis in Q4, buying 28,756 shares valued at about $3.62 million, and institutional investors now own roughly 92.8% of the company.
• Wall Street sentiment is mixed—consensus rating is Hold (7 Buys, 7 Holds, 1 Sell) with a consensus price target of $152.25, while Zoetis shares were trading around $117.85.
• Zoetis beat Q4 estimates (EPS $1.48 vs. $1.40), issued FY2026 guidance of 7.00–7.10 EPS, and declared a quarterly dividend of $0.53 (annualized $2.12, ~1.8% yield).

Cadence Bank purchased a new position in Zoetis Inc. (NYSE:ZTS - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 28,756 shares of the company's stock, valued at approximately $3,618,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Global Wealth Strategies & Associates acquired a new position in shares of Zoetis in the 4th quarter worth approximately $25,000. Lodestone Wealth Management LLC acquired a new position in shares of Zoetis during the 4th quarter valued at $30,000. KERR FINANCIAL PLANNING Corp acquired a new position in shares of Zoetis during the 3rd quarter valued at $31,000. Holos Integrated Wealth LLC acquired a new position in shares of Zoetis during the 4th quarter valued at $32,000. Finally, Board of the Pension Protection Fund acquired a new position in shares of Zoetis during the 4th quarter valued at $38,000. Institutional investors and hedge funds own 92.80% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on ZTS. Leerink Partners reiterated a "market perform" rating on shares of Zoetis in a research report on Tuesday, March 10th. Weiss Ratings downgraded shares of Zoetis from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Friday, March 27th. Piper Sandler reiterated a "neutral" rating and set a $135.00 target price (down from $190.00) on shares of Zoetis in a research report on Thursday, January 22nd. Citigroup began coverage on shares of Zoetis in a research report on Wednesday, April 15th. They set a "buy" rating and a $145.00 target price on the stock. Finally, Bank of America boosted their target price on shares of Zoetis from $135.00 to $140.00 and gave the company a "neutral" rating in a research report on Friday, February 13th. Seven analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Zoetis presently has an average rating of "Hold" and a consensus price target of $152.25.

Zoetis Stock Up 0.8%

Zoetis stock opened at $117.85 on Tuesday. The company has a market capitalization of $49.57 billion, a PE ratio of 19.58, a PEG ratio of 1.78 and a beta of 0.98. The firm's fifty day moving average is $120.65 and its 200 day moving average is $125.10. The company has a quick ratio of 1.94, a current ratio of 3.03 and a debt-to-equity ratio of 2.71. Zoetis Inc. has a 12-month low of $113.29 and a 12-month high of $172.23.

Zoetis (NYSE:ZTS - Get Free Report) last announced its quarterly earnings results on Thursday, February 12th. The company reported $1.48 EPS for the quarter, beating analysts' consensus estimates of $1.40 by $0.08. The business had revenue of $2.39 billion during the quarter, compared to analyst estimates of $2.36 billion. Zoetis had a net margin of 28.24% and a return on equity of 62.02%. Zoetis's quarterly revenue was up 3.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.40 EPS. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. As a group, sell-side analysts predict that Zoetis Inc. will post 7.02 EPS for the current fiscal year.

Zoetis Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 2nd. Shareholders of record on Monday, April 20th will be paid a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date is Monday, April 20th. Zoetis's payout ratio is 35.22%.

About Zoetis

Zoetis Inc NYSE: ZTS is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company's offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.